Clinical Cancer Research

Strengthening Rising Tide Foundations for Clinical Cancer Research Connections in Australia August 13, 2026 Rising Tide Foundation for Clinical Cancer Research (RTFCCR) recently attended the MASCC/ISOO 2026 Annual Meeting from June 25th-27th in Melbourne, Australia. The conference provided a platform to promote international clinical research in supportive cancer care, including several of the RTFCCR’s grantees. The team also conducted two site visits to leading Australian organizations in cancer […]

Rising Tide Webinar Series Highlights Success Stories of Patient and Community Engagement in Cancer Research in LMICs August 6, 2026 The Partnering with Patients to Improve Clinical Trials webinar series, developed by the Rising Tide Foundation for Clinical Cancer Research in collaboration with the LUNGevity Foundation, recently released a new episode showcasing impactful stories of patient partner

Amplifying Patient Voice in Early-Phase Trials: Insights from Patient Expert Roundtable during ASCO 2026 July 9, 2026 Rising Tide Foundation for Clinical Cancer Research (RTFCCR) convened a Patient Expert Roundtable during ASCO 2026 in Chicago, bringing together leading patient advocates to explore how patient perspectives can more meaningfully shape early-phase clinical trials. Early-phase trials (Phase

Strengthening collaboration with UT MD Anderson researchers June 15, 2026 Rising Tide Foundation for Clinical Cancer Research (RTFCCR) recently conducted a two-day site visit to The University of Texas MD Anderson Cancer Center in Houston, reinforcing its commitment to advancing innovative, patient-centered clinical research through strong institutional collaborations. Held on June 3–4, 2026, the visit

Celebrating the LYMPH Trial – Winner of the Amplify Award June 12, 2026 Introducing the Amplify Award Recognizing Patient-Researcher Partnerships that shape cancer research.  Rising Tide Foundation for Clinical Cancer Research (RTFCCR) proudly presents the Amplify Award, celebrating the collaboration between patients and researchers that has made the biggest difference in how a clinical trial is designed, run and experienced. Out of 62 ongoing trials within our funding

RTFCCR and Anticancer Fund Launch Ingenious, a Joint Call to Support Innovative Treatment Strategies to Improve Cancer Survival May 8, 2026 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the Anticancer Fund (ACF) have launched Ingenious, a new joint Call for Research Projects (CfRP) aimed at supporting academic‑led clinical trials evaluating whether treatment strategies that incorporate predictive information can improve patient